Alnylam Pharmaceuticals, Inc. (ETR:DUL)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	52,026	29,316	21,731	27,358	17,834	12,344
Market Cap Growth	82.32%	34.90%	-20.57%	53.40%	44.47%	7.89%
Enterprise Value	52,068	29,263	21,965	27,663	17,475	11,967
Last Close Price	393.00	-	227.20	227.20	150.30	106.54
PS Ratio	19.02	13.50	13.14	28.18	24.02	30.64
PB Ratio	260.98	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	260.98	452.40	-	-	34.48	14.86
P/FCF Ratio	275.76	-	572.67	-	-	-
P/OCF Ratio	229.60	-	230.62	-	-	-
EV/Sales Ratio	18.87	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	275.98	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.07%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.36%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.